Strategic Advocates’s Accenture ACN Stock Holding History

Strategic Advocates’s Portfolio ACN Stock Details ACN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2	Closed	-$540	–	273
2025 Q4	$540	Hold	2	–	–	﹤0.01%	543
2025 Q3	$493	Buy	+2	New	+$522	﹤0.01%	528

Other funds holding ACN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Strategic Advocates's ACN Position: Q1 2026 in Review

Strategic Advocates sold out of Accenture (ACN) in Q1 2026, closing a stake of 2 shares — an estimated $540 sold.

Strategic Advocates first reported a position in ACN in Q3 2025 and held it in 2 quarters. The position peaked at $540 in Q4 2025. 2,149 funds tracked by Wall St. Rank hold ACN as of Q1 2026.

Strategic Advocates reported no remaining Accenture position as of Q1 2026 after selling out during the quarter.
Strategic Advocates sold 2 Accenture shares in Q1 2026, an estimated $540.
Strategic Advocates first reported a position in Accenture in Q3 2025 and held it in 2 quarters.
Strategic Advocates's Accenture position peaked at $540 in Q4 2025.
2,149 funds tracked by Wall St. Rank held Accenture as of Q1 2026.

Based on Strategic Advocates's 13F filing for Q1 2026, filed 15 May 2026.